False News, No Killer Anti-Malaria Drugs In Nigeria, says NAFDAC
Just last week here, the Nigeria House of Senate raised an alarm of killer malaria drugs, as reported by several online media. However, Yesterday NAFDAC has come with claims to justify such information as false news.
The Acting Director-General, NAFDAC, Dr. Yetunde Oni, who stated this yesterday at a news conference in Lagos, has debunked the spreed of false news on the media previous week of fake medical anti-malaria durgs, which was reported to be ‘Kidney-killer’ malaria drugs as there are no such drugs in the country.
Against the backdrop of the dangers posed by the drugs, the Senate had flayed the NAFDAC and Standards Organisation of Nigeria (SON) for not adequately waging the war against the influx of fake and sub-standard items into the country.
- I am sure You are transform by the information you get through me, I am also sure you can be part of our daily updates. why not leave your email behind let me keep you informed with information, jobs and inspire you always.
The NAFDAC boss said the allegedly banned drugs are oral monotherapies containing single Active Pharmaceutical Ingredients (API) such as Artesunate as contained in Arinate tablet, Amodiaquine contained in Comoquine, Dihydroartemisinin contained in Alaxin tablets and Pyrimethamine contained in Daraprim tablets which are not recommended for the treatment of malaria in Nigeria.
She said the agency is committed to the well-being of Nigerians and so wishes to douse the tension and correct the misinformation on the social media and mainstream media about the banned drugs.
Oni said: “We want to douse the tension and correct the misinformation on the social and mainstream media about the 42 anti-malaria medicines purportedly banned by the European Union (EU) but allegedly circulating in the country.
The Acting DG, therefore, urged Nigerians to use the recommended anti-malarial medicine Artemisin Combination Therapies (ACTs) for the treatment of malaria, which is in line with the guidelines according to the WHO and the Nigeria National Anti-malarial Treatment Policy.